Gufic Biosciences promotes Shekhar Tarbir Aley to President - Critical Care SBUs, Nepal & Institution
Advertisement
Mumbai: Gufic Biosciences has announced the promotion of Shekhar Tarbir Aley from Senior Vice President - Critical Care SBUs, Nepal & Institution to President - Critical Care SBUs, Nepal & Institution, and continues to be Senior Management Personnel of the Company.
"we wish to inform you that on the basis of recommendation of Nomination & Remuneration Committee, the Board of Directors vide Circular Resolution passed on September 16, 2025 has approved the Promotion and Re-designation of Mr. Shekhar Tarbir Aley as President – Critical Care SBUs, Nepal & Institution, Senior Management Personnel of the Company with effect from September 16, 2025," the company stated in a BSE filing.
He is also pursuing higher studies Doctorate in Business Administration (DBA). He is an experienced pharmaceutical leader with over 30 years of diverse experience in hospital-focused business units, with a deep-rooted specialization in Critical Care therapies.
Known for driving strategic growth in complex, high- dependence segments, he brings a strong blend of scientific engagement, commercial acumen and operational leadership.
In his previous roles, he played a pivotal part in positioning companies as credible partners and trusted solution providers in the critical care business. He successfully built strong relationships with key opinion leaders, business leaders, and leading tertiary as well as secondary care hospitals across India and Nepal by addressing critical clinical challenges.
To capture PAN India small and district town critical care business opportunities under his leadership Prima Care Division was launched. Under his leadership, the division has already achieved notable success with small town critical care practitioners, secondary care hospitals, and nursing homes.
With a strong track record in critical care business development, scientific brand building, key customers’ engagement, people development and cross-functional team leadership, he is well- positioned to lead the the company's Critical Care Division’s into its next phase of transformation and growth.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.